The following is an update provided by Public Health England
(PHE) on the supply situation for vaccines purchased direct from the manufacturers (e.g. for travel and risk groups):
Diphtheria, Tetanus and Poliomyelitis (inactivated) Vaccine
Sanofi Pasteur: Limited supplies of Revaxis are available. There are likely to be order restrictions in place for travellers. Please contact Sanofi Pasteur for information regarding availability. Sanofi Pasteur Tel: 0148 350 5515.
Hepatitis B
To ensure vaccine availability for those at highest and most immediate risk of exposure to hepatitis B, all hepatitis B containing monovalent and bivalent (HepA/HepB) vaccines are currently under supply management processes. The update specific to travellers was published by PHE in November 2017 and can be accessed alongside other associated guidance here
In Scotland a mechanism is in place to allow for exceptional orders if there is an urgent and immediate need for an individual following a thorough risk assessment, this is through the local NHS Board Vaccine Holding Centre
Hep B Adult:
- GSK: Engerix B PFS singles are available.
- GSK: Engerix B PFS packs of 10 are available.
- GSK: Very limited supplies of Engerix B vials are available.
- GSK: Fendrix is available.
- MSD: Limited supplies of HBVAXPRO 10μg are available. Supplies are expected to be restricted throughout 2018.
- MSD: Limited supplies of HBVAXPRO 40μg are available. Supplies are expected to be restricted throughout 2018.
Hep B Paediatric:
- GSK: Engerix B Paediatric singles are available.
- MSD: Limited supplies of HBVAXPRO 5μg are available. Supplies are expected to be restricted throughout 2018.
Hepatitis A Vaccine
Hep A Adult:
- GSK: Supplies of Havrix PFS singles, PFS packs of 10 and vials in singles are available. However, there may not be sufficient stock in each presentation to accommodate demand.
- Sanofi Pasteur: Avaxim is currently out of stock, limited supplies are expected in May 2018.
- MSD: VAQTA is currently unavailable and there will be intermittent supplies of during 2018.
Hepatitis A Paediatric:
- GSK: Havrix Paediatric singles and packs of 10 are currently available.
- MSD: VAQTA Paediatric is currently available with supplies expected throughout 2018.
Combined Hepatitis A and B
- GSK: Twinrix Adult and Paediatric presentations are available.
- GSK: Ambirix is available.
Combined Hepatitis A and Typhoid
- GSK: GSK is discontinuing Hepatyrix vaccine that has been under constrained supply for several years due to challenges associated with its manufacturing.
- Sanofi Pasteur: Viatim is currently unavailable, it is likely to become available in May 2018.
Meningitis ACWY Vaccine
- GSK: Menveo is heavily constrained and supply is anticipated to improve in late 2018.
- Pfizer: Nimenrix is currently available for private sales and there is no current impact on the National Immunisation Programme.
Typhoid
- GSK: GSK is discontinuing Typherix vaccine that has been under constrained supply for several years due to challenges associated with its manufacturing.
- Sanofi Pasteur: Typhim is available to order without restrictions.
- PaxVax: Vivotif is available.
Rabies
- GSK: limited supplies of Rabipur are available. Supply is being prioritised to hospitals and GPs for use in notified post exposure cases only.
- Sanofi Pasteur: Limited supplies of Rabies BP are available. It is likely that there will be order restrictions in place.
Contact Details:
GSK Tel: 0208 047 5000
GSK Supply Portal: https://hcp.gsk.co.uk/supply.html
Sanofi Pasteur Tel: 0148 350 5515
Sanofi Supply Portal: https://www.sanofipasteur-portal.co.uk/supply.php
MSD Tel: 0199 245 2094
PaxVax Tel: 0152 521 7516
